The Medical Letter on Drugs and Therapeutics
FROM
ISSUE 1546
ISSUE 1546
May 7, 2018
Issue 1546
Subscribers: Log in to read full issue. Not a subscriber? Subscribe or purchase issue.
Adult Immunization
May 7, 2018 (Issue: 1546)
The US Advisory Committee on Immunization Practices
(ACIP) recommends routine use of the following
vaccines in adults residing in the US: influenza, tetanus/diphtheria alone (Td) and in combination with acellular
pertussis (Tdap),...more
- DK Kim et al. Advisory Committee on Immunization Practices recommended immunization schedule for adults aged 19 years or older – United States, 2018. MMWR Morb Mortal Wkly Rep 2018; 67:158.
- Influenza vaccine for 2017-2018. Med Lett Drugs Ther 2017; 59:163.
- Vaccines for travelers. Med Lett Drugs Ther 2014; 56:115.
- Centers for Disease Control and Prevention (CDC). Epidemiology and prevention of vaccine-preventable diseases (The Pink Book). J Hamborsky et al. eds. 13th ed. Washington D.C. Public Health Foundation, 2015. Available at: www.cdc.gov. Accessed April 26, 2018.
- Adacel and Boostrix: Tdap vaccines for adolescents and adults. Med Lett Drugs Ther 2006; 48:5.
- Centers for Disease Control and Prevention (CDC). Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap) in pregnant women – Advisory Committee on Immunization Practices (ACIP), 2012. MMWR Morb Mortal Wkly Rep 2013; 62:131.
- Centers for Disease Control and Prevention (CDC). ACIP Meeting Summary Report, October 2016. Available at: https://www.cdc.gov. Accessed April 26, 2018.
- Centers for Disease Control and Prevention. Measles – United States, January 1-May 3, 2014. MMWR Morb Mortal Wkly Rep 2014; 63:496.
- JP Albertson et al. Mumps outbeak at a university and recommendation for a third dose of measles-mumps-rubella vaccine—Illinois, 2015-2016. MMWR Morb Mortal Wkly Rep 2016; 65:731.
- HQ McLean et al. Prevention of measles, rubella, congenital rubella syndrome, and mumps, 2013: summary recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2013; 62(RR-4):1.
- M Marin et al. Recommendation of the Advisory Committee on Immunization Practices for use of a third dose of mumps virus-containing vaccine in persons at increased risk for mumps during an outbreak. MMWR Morbid Mortal Wkly Rep 2018; 67:33.
- M Marin et al. Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2007; 56 (RR-4):1.
- Shingrix – an adjuvanted, recombinant herpes zoster vaccine. Med Lett Drugs Ther 2017; 59:195.
- MN Oxman et al. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med 2005; 352:2271.
- KE Schmader et al. Efficacy, safety, and tolerability of herpes zoster vaccine in persons aged 50-59 years. Clin Infect Dis 2012; 54:922.
- R Baxter et al. Long-term effectiveness of the live zoster vaccine in preventing shingles: a cohort study. Am J Epidemiol 2018; 187:161.
- H Lal et al. Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults. N Engl J Med 2015; 372:2087.
- AL Cunningham et al. Efficacy of the herpes zoster subunit vaccine in adults 70 years of age or older. N Engl J Med 2016; 375:1019.
- KL Dooling et al. Recommendations of the Advisory Committee on Immunization Practices for use of herpes zoster vaccines. MMWR Morb Mortal Wkly Rep 2018; 67:103.
- Gardasil 9 - a broader HPV vaccine. Med Lett Drugs Ther 2015; 57:47.
- E Petrosky et al. Use of 9-valent human papillomavirus (HPV) vaccine: updated HPV vaccination recommendations of the Advisory Committee on Immunization Practices. MMWR Morb Mortal Wkly Rep 2015; 64:300.
- WK Huh et al. Final efficacy, immunogenicity, and safety analyses of a nine-valent human papillomavirus vaccine in women aged 16-26 years: a randomised, double-blind trial. Lancet 2017; 390:2143.
- E Meites et al. Use of a 2-dose schedule for human papillomavirus (HPV) vaccination – updated recommendations of the Advisory Committee on Immunization Practices. MMWR Morb Mortal Wkly Rep 2016; 65:1405.
- NM Scheller et al. Quadrivalent HPV vaccination and the risk of adverse pregnancy outcomes. N Engl J Med 2017; 376:1223.
- HS Lipkind et al. Maternal and infant outcomes after human papillomavirus vaccination in the periconceptional period or during pregnancy. Obstet Gynecol 2017; 130:599.
- Pneumococcal vaccine for adults. Med Lett Drugs Ther 2012; 54:87.
- MJ Bonten et al. Polysaccharide conjugate vaccine against pneumococcal pneumonia in adults. N Engl J Med 2015; 372:1114.
- Centers for Disease Control and Prevention (CDC) and Advisory Committee on Immunization Practices. Updated recommendations for prevention of invasive pneumococcal disease among adults using the 23-valent pneumococcal polysaccharide vaccine (PPSV23). MMWR Morb Mortal Wkly Rep 2010; 59:1102.
- G Falkenhorst et al. Effectiveness of the 23-valent pneumococcal polysaccharide vaccine (PPV23) against pneumococcal disease in the elderly: systematic review and meta-analysis. PLoS One 2017; 12:e0169368.
- O Ochoa-Gondar et al. Effectiveness of the 23-valent pneumococcal polysaccharide vaccine against community-acquired pneumonia in the general population age ≥60 years: 3 years of follow-up in the CAPAMIS study. Clin Infect Dis 2014; 58:909.
- M Suzuki et al. Serotype-specific effectiveness of 23-valent pneumococcal polysaccharide vaccine against pneumococcal pneumonia in adults aged 65 years or older: a multicenter, prospective, test-negative design study. Lancet Infect Dis 2017; 17:313.
- M Kobayashi et al. Intervals between PCV13 and PPSV23 vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 2015; 64:944.
- Centers for Disease Control and Prevention (CDC). Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine for adults with immunocompromising conditions: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 2012; 61:816.
- Centers for Disease Control and Prevention (CDC). Pneumococcal vaccine timing for adults. November 30, 2015. Available at: www.cdc.gov. Accessed April 26, 2018.
- Centers for Disease Control and Prevention (CDC). Surveillance for viral hepatitis – United States, 2015. Available at: www.cdc.gov. Accessed April 26, 2018.
- NF Eng et al. The potential of 1018 ISS adjuvant in hepatitis B vaccines: Heplisav™ review. Hum Vaccin Immunother 2013; 9:1661.
- A two-dose hepatitis B vaccine for adults (Heplisav-B). Med Lett Drugs Ther 2018; 60:17.
- S Jackson et al. Immunogenicity of a two-dose investigational hepatitis B vaccine, HBsAg-1018, using a toll-like receptor 9 agonist adjuvant compared with a licensed hepatitis B vaccine in adults. Vaccine 2018; 36:668.
- Centers for Disease Control and Prevention (CDC). Prevention of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices. MMWR Recomm Rep 2018; 67(RR-1):1.
- Centers for Disease Control and Prevention (CDC). Use of hepatitis B vaccination for adults with diabetes mellitus: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 2011; 60:1709.
- S Schillie et al. Recommendations of the Advisory Committee on Immunization Practices for use of a hepatitis B vaccine with a novel adjuvant. MMWR Morb Mortal Wkly Rep 2018; 67:455.
- A new conjugate meningococcal vaccine (Menveo). Med Lett Drugs Ther 2010; 52:59.
- KS Reisinger et al. Quadrivalent meningococcal vaccination of adults: phase III comparison of an investigational conjugate vaccine, MenACWY-CRM, with the licensed vaccine, Menactra. Clin Vaccine Immunol 2009; 16:1810.
- HM Soeters et al. Serogroup B meningococcal disease outbreak and carriage evaluation at a college – Rhode Island, 2015. MMWR Morb Mortal Wkly Rep 2015; 64:606.
- LA McNamara et al. First use of serogroup B meningococcal vaccine in the US in response to a university outbreak. Pediatrics 2015; 135:798.
- Bexsero – a second serogroup B meningococcal vaccine. Med Lett Drugs Ther 2015; 57:158.
- Trumenba: a serogroup B meningococcal vaccine. Med Lett Drugs Ther 2015; 57:5.
- AC Cohn et al. Prevention and control of meningococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2013; 62(RR-2):1.
- T Folaranmi et al. Use of serogroup B meningococcal vaccines in persons aged ≥10 years at increased risk for serogroup B meningococcal disease: recommendations of the Advisory Committee on Immunization Practices, 2015. MMWR Morb Mortal Wkly Rep 2015; 64:608.
- HM Soeters et al. Current epidemiology and trends in invasive Haemophilus influenzae disease–United States, 2009-2015. Clin Infect Dis 2018 March 2 (epub).
- EC Briere et al. Prevention and control of Haemophilus influenzae type b disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2014; 63(RR-1):1.
- M Doshani et al. Recommendations of the Advisory Committee on Immunization Practices for use of hepatitis A vaccine for persons experiencing homelessness. MMWR Morb Mortal Wkly Rep 2019; 68:153.
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.
Would you like to read the rest of this issue? Gain access below.
Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
- Print version published and mailed biweekly (26 issues/year)
- Unlimited online access to current and past issues (1988 - present)
- Mobile App
- FREE online per issue CME/CE
Purchase this issue:
Title: Issue 1546
Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.